<?xml version="1.0" encoding="UTF-8"?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://www.saber.ula.ve/handle/123456789/2337">
<title>Articulos, Pre-prints (Laboratorio de Microbiología y Salud Pública del Estado Mérida. ULA-ULE)</title>
<link>http://www.saber.ula.ve/handle/123456789/2337</link>
<description>Articulos, Pre-prints del Laboratorio de Microbiología y Salud Pública del Estado Mérida. ULA-ULE</description>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://www.saber.ula.ve/handle/123456789/16111"/>
<rdf:li rdf:resource="http://www.saber.ula.ve/handle/123456789/16103"/>
<rdf:li rdf:resource="http://www.saber.ula.ve/handle/123456789/16105"/>
<rdf:li rdf:resource="http://www.saber.ula.ve/handle/123456789/16109"/>
<rdf:li rdf:resource="http://www.saber.ula.ve/handle/123456789/16107"/>
</rdf:Seq>
</items>
<dc:date>2026-05-16T02:56:52Z</dc:date>
</channel>
<item rdf:about="http://www.saber.ula.ve/handle/123456789/16111">
<title>Correspondence</title>
<link>http://www.saber.ula.ve/handle/123456789/16111</link>
<description>Correspondence
Pérez, Saberio
</description>
<dc:date>2007-04-25T09:00:00Z</dc:date>
</item>
<item rdf:about="http://www.saber.ula.ve/handle/123456789/16103">
<title>Uso de Aripiprazol en adolescente con esquizofrenia refractaria.</title>
<link>http://www.saber.ula.ve/handle/123456789/16103</link>
<description>Uso de Aripiprazol en adolescente con esquizofrenia refractaria.
Pérez Lo Presti, Alirio; Pérez Lo Presti, Annabelle; Pérez, Saberio; Dávila Federico, José
Uso de Aripiprazol en adolescente con esquizofrenia refractaria.
A propósito de un caso.
Pérez Lo Presti, Alirio; Pérez Lo Presti, Annabelle; Pérez Lo Presti, Saberio y Dávila Federico, José

Resumen
El presente trabajo reporta el caso de un adolescente masculino con síntomas psicóticos recurrentes y hospitalizaciones desde los doce años de edad.
Luego de múltiples tratamientos farmacológicos, respondió favorablemente al uso de aripiprazol a dosis de 22,5 mg., permaneciendo asintomático durante un año de seguimiento.


Abstract
This study reports a case of a male adolescent with psychotic recurrent symptoms who was repeatedly referred to the hospital since the age of twelve years old. After receiving multiple pharmacological treatments, he responded well to aripiprazol (22,5 mg. / day). During the following year he was free of any psychopathological symptom.
</description>
<dc:date>2007-03-28T09:00:00Z</dc:date>
</item>
<item rdf:about="http://www.saber.ula.ve/handle/123456789/16105">
<title>A simple algorithm for the diagnosis of AIDS associated genitourinary tuberculosis.</title>
<link>http://www.saber.ula.ve/handle/123456789/16105</link>
<description>A simple algorithm for the diagnosis of AIDS associated genitourinary tuberculosis.
Pérez, Saberio; Bracho, Yoshira; Andrade, Martin; Bergel, Patrick; Waard, Jacobus
</description>
<dc:date>2007-03-28T09:00:00Z</dc:date>
</item>
<item rdf:about="http://www.saber.ula.ve/handle/123456789/16109">
<title>Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of fc y receptor II (FCyRII)</title>
<link>http://www.saber.ula.ve/handle/123456789/16109</link>
<description>Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of fc y receptor II (FCyRII)
Vielma, Silvana; Virella, Gabriel; Gorod, Adam J.; Lopes Virella, Maria F.
Chlamydophila pneumoniae infection of human aortic endothelial cells induces the expression of fc y receptor II (FCyRII).

(Vielma, Silvana;  Virella, Gabriel; Gorod, Adam J.; Lopes Virella, Maria F.)


Abstract


Chronic endothelial infection is believed to be one of
the factors able to cause endothelial cell damage and
trigger the onset of human atherosclerosis. Chlamydophila
pneumoniae infects endothelial cells and has
received special attention because of both epidemiological
and experimental evidence supporting its role
as a risk factor for atherosclerosis. It is also possible
that otherwise independent risk factors for atherosclerosis
may have synergistic effects. Immune phenomena,
such as the formation of circulating immune
complexes (IC) containing modified LDL and corresponding
antibodies, have been linked to the development
of coronary artery disease. The antibodies
involved in the immune response to modified lipoproteins
are predominantly of the pro-inflammatory IgG1
and IgG3 subclasses. However, it is difficult to understand
how circulating IC could cause endothelial damage
and initiate the atherosclerotic process, unless
they were formed in the subendothelial space or immobilized
by endothelial cells. The last hypothesis
would be possible if endothelial cells expressed Fcy
receptors. Healthy endothelial cells do not express Fcy
receptors, but endothelial cells infected by a variety of
infectious agents do. Thus we decided to investigate
whether infection of endothelial cells with C. pneumoniae
is also able to cause the expression of Fcy
receptors. The expression of Fcy receptors (CD64, 32,
and 16) on human aortic endothelial cells infected
with C. pneumoniae for 4, 24, 36, and 48 h was studied
by flow cytometry. Twenty-four hours after infection
30-40% of the endothelial cells had detectable inclusion
bodies, 8-9% of the total number of cells (approximately
25% of the infected cells) expressed FcyRII,
and about 1.5-2% (5% of infected cells) expressed
FcyRI and FcyRIII. Double-staining studies confirmed
that the expression of FcyRII was limited to C. pneumoniae-
infected endothelial cells. We conclude that C.
pneumoniae infection induces primarily the expression
of FcyRII by endothelial cells and this may be a
significant link between two proposed pathogenic
mechanisms involved in the pathogenesis of human
atherosclerosis.

Published on: Clinical Immunology
Vol. 104, No. 3, September, pp. 265-273, 2002
doi:10.1006/clim.2002.5237
</description>
<dc:date>2006-02-24T09:00:00Z</dc:date>
</item>
<item rdf:about="http://www.saber.ula.ve/handle/123456789/16107">
<title>Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase c-dependent activation of nuclear factor-kb.</title>
<link>http://www.saber.ula.ve/handle/123456789/16107</link>
<description>Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase c-dependent activation of nuclear factor-kb.
Vielma, Silvana; Lopes Virella, Maria F.; Krings, Gregor
Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase c-dependent activation of nuclear factor-kb.

(Vielma, Silvana; Krings, Gregor; Lopes Virella, Maria F.)


Abstract


Chlamydophila pneumoniae has an epidemiological link with atherosclerosis and acute cardiovascular events.
One mechanism that may explain such a link is the increased expression of intracellular adhesion molecule-1 (ICAM-1)
in C pneumoniae-infected endothelial cells. Upregulation of ICAM-1 by C pneumoniae is well recognized and has been
extensively studied, but the signaling pathways involved are not yet defined. Because upregulation of ICAM-1 by
cytokines and other stimuli has been shown to be mediated by either mitogen-activated protein kinase, protein kinase
C (PKC), or nuclear factor-kB (NF-kB) pathways, we examined whether these pathways were involved in the ICAM-1
upregulation induced by C pneumoniae. Our data show a time-dependent phosphorylation of p44/p42 and SAPK/JNK
pathways in C pneumoniae-infected cells. However, inhibition of the classic mitogen-activated protein kinase pathway
using the PD98059 and U0126 inhibitors and inhibition of SAPK/JNK pathway did not suppress C pneumoniae-induced
ICAM-1 expression. C pneumoniae also activates the NF-kB pathway at 30 minutes after infection. Treatment of human
aortic endothelial cells (HAECs) with the NF-kB inhibitors BAY117085 and caffeic acid phenethyl ester led to a
concentration-dependent inhibition of C pneumoniae-induced ICAM-1 upregulation. Finally, C pneumoniae-infected
HAECs show membrane translocation of total PKC 30 minutes after cell infection. Calphostin C, a general PKC
inhibitor, blocked both C pneumoniae-induced ICAM-1 expression and C pneumoniae-induced NF-kB translocation.
In conclusion, we demonstrated that C pneumoniae-induced ICAM-1 expression in HAECs requires NF-kB and PKC
activation and that NF-kB activation is PKC dependent.
</description>
<dc:date>2005-07-25T09:00:00Z</dc:date>
</item>
</rdf:RDF>
